Gene · 3206
Papers2,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool. | Int J Mol Sci | 2022 | 36614080 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs as Epigenetic Regulators of Immune Checkpoints in Cancer Immunity. | Cancers (Basel) | 2022 | 36612180 | PubTator, text mining | PubMed |
| Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC). | Cancers (Basel) | 2022 | 36612107 | PubTator, text mining | PubMed |
| Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes. | Cancers (Basel) | 2022 | 36612014 | PubTator, text mining | PubMed |
| Nuclear envelope, chromatin organizers, histones, and DNA: The many achilles heels exploited across cancers. | Front Cell Dev Biol | 2022 | 36589746 | PubTator, text mining | PubMed |
| Role of mechano-sensitive non-coding RNAs in bone remodeling of orthodontic tooth movement: recent advances. | Prog Orthod | 2022 | 36581789 | PubTator, text mining | PubMed |
| Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients. | BMC Cancer | 2022 | 36572856 | PubTator, text mining | PubMed |
| Editorial: Molecular and cytogenetic research advances in human reproduction. | Front Endocrinol (Lausanne) | 2022 | 36568095 | PubTator, text mining | PubMed |
| The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets. | Front Oncol | 2022 | 36561529 | PubTator, text mining | PubMed |
| Human Umbilical Cord-Based Therapeutics: Stem Cells and Blood Derivatives for Female Reproductive Medicine. | Int J Mol Sci | 2022 | 36555583 | PubTator, text mining | PubMed |
| Integrative Meta-Analysis of Huntington's Disease Transcriptome Landscape. | Genes (Basel) | 2022 | 36553652 | PubTator, text mining | PubMed |
| Upfront Screening by Quantitative Real-Time PCR Assay Identifies NUP98::NSD1 Fusion Transcript in Indian AML Patients. | Diagnostics (Basel) | 2022 | 36553008 | PubTator, text mining | PubMed |
| Contribution of Non-Coding RNAs to Anticancer Effects of Dietary Polyphenols: Chlorogenic Acid, Curcumin, Epigallocatechin-3-Gallate, Genistein, Quercetin and Resveratrol. | Antioxidants (Basel) | 2022 | 36552560 | PubTator, text mining | PubMed |
| Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis. | Front Endocrinol (Lausanne) | 2022 | 36545327 | PubTator, text mining | PubMed |
| A promising future for endometriosis diagnosis and therapy: extracellular vesicles - a systematic review. | Reprod Biol Endocrinol | 2022 | 36544197 | PubTator, text mining | PubMed |
| Gene expression analysis in endometriosis: Immunopathology insights, transcription factors and therapeutic targets. | Front Immunol | 2022 | 36532015 | PubTator, text mining | PubMed |
Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis. | BMC Pregnancy Childbirth | 2022 | 36528566 | PubTator, text mining | PubMed |
| Comparison of clinical effects between early follicular prolonged GnRH agonist protocol and GnRH antagonist protocol in 3310 cycles: a retrospective study. | BMC Pregnancy Childbirth | 2022 | 36522703 | PubTator, text mining | PubMed |
| Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD. | BMC Med Genomics | 2022 | 36522691 | PubTator, text mining | PubMed |
| Biological and pharmacological roles of m6A modifications in cancer drug resistance. | Mol Cancer | 2022 | 36517820 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3206/papers?page=22